Virtu Financial LLC Eloxx Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022
BUY
$0.15 - $7.2 $2,239 - $107,503
14,931 New
14,931 $3,000
Q2 2022

Aug 09, 2022
SELL
$0.24 - $0.58 $4,920 - $11,892
-20,504 Closed
0 $0
Q1 2022

May 17, 2022
SELL
$0.4 - $0.72 $43,906 - $79,031
-109,766 Reduced 84.26%
20,504 $11,000
Q4 2021

Feb 17, 2022
BUY
$0.62 - $1.61 $80,767 - $209,734
130,270 New
130,270 $91,000

About Eloxx Pharmaceuticals, Inc.

ELOX Quotes by TradingView
  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email